Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors in patients with cancers of unknown primary.
Rassy, Elie; Karam, Elias; Adeleke, Sola; Okoli, Somto; Galante, Joao; Boussios, Stergios; Pavlidis, Nicholas.
Afiliação
  • Rassy E; Gustave Roussy, Départements de Médecine Oncologique, F-94805 Villejuif, France; Université Paris-Saclay, Gustave Roussy, Institut national de la santé et de la recherche médicale (INSERM), U1018 Villejuif, France. Electronic address: elie.el-rassy@gustaveroussy.fr.
  • Karam E; Gustave Roussy, Départements de Médecine Oncologique, F-94805 Villejuif, France.
  • Adeleke S; School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom; Department of Oncology, Guy's & St Thomas' Hospital, London, United Kingdom.
  • Okoli S; Bristol Medical School, University of Bristol, Bristol, UK.
  • Galante J; Department of Oncology, Guy's & St Thomas' Hospital, London, United Kingdom.
  • Boussios S; Department of Medical Oncology, Medway NHS Foundation Trust, Windmill Road, Gillingham ME7 5NY, UK; Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, UK; Kent Medway Medical School, University of Kent, Canterbury CT2 7LX,
  • Pavlidis N; University of Ioannina, 45110 Ioannina, Greece.
Eur J Cancer ; 195: 113377, 2023 12.
Article em En | MEDLINE | ID: mdl-37890352

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Antineoplásicos Imunológicos Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Antineoplásicos Imunológicos Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article